Psylink is a biotechnology company offering a novel solution to psychedelic drug development
Location: Lithuania
Total raised: $586.53K
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.07.2025 | Pre-Seed | $586.53K | FIRSTPICK |
Mentions in press and media 2
| Date | Title | Description |
| 29.07.2025 | Coinvest Capital backs Psylink’s next-gen mental health biotech solution | Lithuanian startup Psylink has raised €501,521 in a pre-seed round to develop further its proprietary biotechnology platform, which focuses on the sustainable production of plant- and fungi-derived compounds. Psylink is a deep-tech biotechn... |
| 29.07.2025 | Lithuanian BioTech platform Psylink raises over €500k for mental health innovation | Psylink, a Vilnius-based startup focused on developing innovative treatments for people facing mental health challenges, raised over €500k in a pre-Seed investment round. The round was led by the VC fund Coinvest Capital, with Firstpick and... |